We are live on ! Find out more
GA

General Atlantic Portfolio holdings

AUM $2.15B
1-Year Est. Return 35.02%
This Fund
S&P 500
This Quarter Est. Return
-10.75%
1 Year Est. Return
+35.02%
3 Year Est. Return
+185.68%
5 Year Est. Return
+122.28%
10 Year Est. Return
+1,080.07%
AUM
$7.56B
AUM Growth
-$935M
Cap. Flow
+$274M
Cap. Flow %
3.62%
Top 10 Hldgs %
86.6%
Holding
42
New
3
Increased
3
Reduced
–
Closed
9

Top Buys

Rank Stock Value
1
MBLY icon
Mobileye
MBLY
+$145M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$64.6M
3
FUTU icon
Futu Holdings
FUTU
+$54.3M
4
HRT
HireRight Holdings Corporation
HRT
+$29.7M
5
IOR
Income Opportunity Realty Investors
IOR
+$29.6M

Top Sells

Rank Stock Value
1
IOT icon
Samsara
IOT
+$29.5M
2
CRWD icon
CrowdStrike
CRWD
+$7.23M
3
GTM
ZoomInfo Technologies
GTM
+$6.27M
4
TEAM icon
Atlassian
TEAM
+$4.03M
5
DT icon
Dynatrace
DT
+$2.86M

Sector Composition

Rank Sector Weight
1 Technology 49.31%
2 Healthcare 33.45%
3 Financials 5.74%
4 Industrials 5.04%
5 Consumer Discretionary 3.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESMT
1
DELISTED
EngageSmart, Inc.
ESMT
$1.71B 22.64%
97,209,436
– –
OSH
2
DELISTED
Oak Street Health, Inc.
OSH
$1.32B 17.47%
61,384,475
– –
DLO icon
3
dLocal
DLO
$4.28B
$898M 11.88%
57,660,766
+349,827
+0.6% +$6.15M
ALHC icon
4
Alignment Healthcare
ALHC
$3.81B
$717M 9.49%
60,993,323
– –
SQSP
5
DELISTED
Squarespace, Inc.
SQSP
$496M 6.56%
22,361,073
– –
XP icon
6
XP
XP
$8.36B
$388M 5.14%
25,317,733
– –
HRT
7
DELISTED
HireRight Holdings Corporation
HRT
$381M 5.04%
32,109,898
+2,390,000
+8% +$29.7M
ALKT icon
8
Alkami Technology
ALKT
$1.96B
$273M 3.62%
18,729,806
– –
YOU icon
9
Clear Secure
YOU
$5.68B
$192M 2.55%
7,013,699
– –
MBLY icon
10
Mobileye
MBLY
$2.03B
$167M 2.21%
+4,761,905
New +$145M
EWCZ
11
DELISTED
European Wax Center
EWCZ
$163M 2.16%
13,110,492
– –
KRTX
12
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$141M 1.86%
716,158
+301,158
+73% +$64.6M
DUOL icon
13
Duolingo
DUOL
$6.55B
$105M 1.39%
1,479,294
– –
ETSY icon
14
Etsy
ETSY
$8.1B
$88.4M 1.17%
737,648
– –
RPRX icon
15
Royalty Pharma
RPRX
$26.6B
$59.3M 0.78%
1,500,000
– –
HCM icon
16
HUTCHMED
HCM
$1.96B
$59.1M 0.78%
4,000,000
– –
DNA icon
17
Ginkgo Bioworks
DNA
$492M
$54.6M 0.72%
807,997
– –
IMCR icon
18
Immunocore
IMCR
$1.68B
$54.2M 0.72%
950,000
– –
CINC
19
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$51.7M 0.68%
4,209,470
– –
FUTU icon
20
Futu Holdings
FUTU
$14.3B
$45.2M 0.6%
+1,111,544
New +$54.3M
IOR
21
Income Opportunity Realty Investors
IOR
$30.4M 0.4%
+2,446,379
New +$29.6M
CNTA
22
DELISTED
Centessa Pharmaceuticals
CNTA
$30M 0.4%
9,681,818
– –
PHVS icon
23
Pharvaris
PHVS
$2.26B
$27.2M 0.36%
2,420,155
– –
RSKD icon
24
Riskified
RSKD
$727M
$24.6M 0.33%
5,324,998
– –
BLND icon
25
Blend Labs
BLND
$436M
$16.5M 0.22%
11,433,949
– –
1
2

Similar funds

NAAA
New Age Alpha Advisors Rye, New York $2.15B AUM 27.2% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return
SC
SouthState Corp Winter Haven, Florida $2.14B AUM 18.39% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
CI
Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return
AAP
Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.16B AUM 18.08% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

General Atlantic's Q4 2022 Portfolio in Review

As of Q4 2022, General Atlantic held 42 positions worth $7.56B, down 11% from $8.49B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

General Atlantic deployed $274M of net new capital in Q4 2022, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Mobileye: 4,761,905 shares worth $167M.

By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 51% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the most notable exit was Samsara, an estimated $29.5M sold.

  • General Atlantic's largest Q4 2022 buy was Mobileye: 4,761,905 shares worth $167M.
  • General Atlantic added most to Karuna Therapeutics, Inc. Common Stock in Q4 2022, an estimated $64.6M increase.
  • General Atlantic fully exited Samsara in Q4 2022, selling an estimated $29.5M.
  • General Atlantic's ten largest holdings make up 87% of its $7.56B portfolio in Q4 2022.
  • General Atlantic opened 3 new positions and closed 9 in Q4 2022.
  • General Atlantic's portfolio value fell 11% quarter-over-quarter to $7.56B.

Based on General Atlantic's 13F filing for Q4 2022, filed 14 Feb 2023.